Agency Information Collection Activities; Proposed eCollection eComments Requested; Regulated Transactions in Tableting/Encapsulating Machines
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Issuing agencies
Abstract
The Drug Enforcement Administration (DEA), Department of Justice (DOJ), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. This proposed information collection was previously published in the Federal Register on September 11, 2023, allowing for a 60-day comment period.
Full Text
<html>
<head>
<title>Federal Register, Volume 88 Issue 220 (Thursday, November 16, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 220 (Thursday, November 16, 2023)]
[Notices]
[Page 78792]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-25327]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
[OMB Number 1117-0024]
Agency Information Collection Activities; Proposed eCollection
eComments Requested; Regulated Transactions in Tableting/Encapsulating
Machines
AGENCY: Drug Enforcement Administration, Department of Justice.
ACTION: 30-Day notice.
-----------------------------------------------------------------------
SUMMARY: The Drug Enforcement Administration (DEA), Department of
Justice (DOJ), will be submitting the following information collection
request to the Office of Management and Budget (OMB) for review and
approval in accordance with the Paperwork Reduction Act of 1995. This
proposed information collection was previously published in the Federal
Register on September 11, 2023, allowing for a 60-day comment period.
DATES: Comments are encouraged and will be accepted for 30 days until
December 18, 2023.
FOR FURTHER INFORMATION CONTACT: If you have comments especially on the
estimated public burden or associated response time, suggestions, or
need a copy of the proposed information collection instrument with
instructions or additional information, please contact Scott A. Brinks,
Regulatory Drafting and Policy Support Section, Drug Enforcement
Administration; Mailing Address: 8701 Morrissette Drive, Springfield,
Virginia 22152; Telephone: (571) 362-3261, email:
<a href="/cdn-cgi/l/email-protection#3546565a41411b541b57475c5b5e46755150541b525a43"><span class="__cf_email__" data-cfemail="2053434f54540e410e4252494e4b53604445410e474f56">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: Written comments and suggestions from the
public and affected agencies concerning the proposed collection of
information are encouraged. Your comments should address one or more of
the following four points:
--Evaluate whether the proposed collection of information is necessary
for the proper performance of the functions of the agency, including
whether the information will have practical utility;
--Evaluate the accuracy of the agency's estimate of the burden of the
proposed collection of information, including the validity of the
methodology and assumptions used;
--Enhance the quality, utility, and clarity of the information to be
collected; and/or
--Minimize the burden of the collection of information on those who are
to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submission of responses.
Written comments and recommendations for this information
collection should be submitted within 30 days of the publication of
this notice on the following website <a href="http://www.reginfo.gov/public/do/PRAMain">www.reginfo.gov/public/do/PRAMain</a>.
Find this particular information collection by selecting ``Currently
under 30-day Review--Open for Public Comments'' or by using the search
function and entering either the title of the information collection or
the OMB Control Number 1117-0024. This information collection request
may be viewed at <a href="http://www.reginfo.gov">www.reginfo.gov</a>. Follow the instructions to view
Department of Justice, information collections currently under review
by OMB.
DOJ seeks PRA authorization for this information collection for
three (3) years. OMB authorization for an ICR cannot be for more than
three (3) years without renewal. The DOJ notes that information
collection requirements submitted to the OMB for existing ICRs receive
a month-to-month extension while they undergo review.
Overview of This Information Collection
1. Type of Information Collection: Revision of a currently approved
collection.
2. Title of the Form/Collection: Regulated Transactions in
Tableting/Encapsulating Machines.
3. Agency form number, if any, and the applicable component of the
Department of Justice sponsoring the collection: DEA Form 452. The
applicable component within the Department of Justice is the Drug
Enforcement Administration, Diversion Control Division.
4. Affected public who will be asked or required to respond, as
well as a brief abstract: Affected public (Primary): Business or other
for-profit. Affected public (Other): Not-for-profit institutions;
Federal, State, local, and tribal governments.
Abstract: Each regulated person is required to report any unusual
or excessive loss or disappearance of a listed chemical, and any
regulated transaction in a tableting or encapsulating machine, to
include any domestic regulated transaction in a tableting or
encapsulating machine and any import or export of a tableting or
encapsulating machine. 21 U.S.C. 830 (b)(1)(A), (C) and (D); 21 CFR
1310.05(a)(1), (3)-(4); 21 CFR 1310.05(c). Regulated persons include
manufacturers, distributors, importers, and exporters of listed
chemicals, tableting machines, or encapsulating machines, or persons
who serve as brokers or traders for international transactions
involving a listed chemical, tableting machine, or encapsulating
machine. 21 CFR 1300.02(b). This report will be submitted
electronically. DEA will be modifying this collection (1117-0024) and
collection 1117-0001 by removing Form 107 from this collection and
adding it to 1117-0001 because DEA Form 107 is more aligned with DEA
Form 106 (which is approved under 1117-0001).
5. Obligation to Respond: Mandatory per 21 CFR 1310.
6. Total Estimated Number of Respondents: 274.
7. Estimated Time per Respondent: 33 minutes.
8. Frequency: 92.
9. Total Estimated Annual Time Burden: 8,367 hours.
10. Total Estimated Annual Other Costs Burden: $0.
If additional information is required, contact: Darwin Arceo,
Department Clearance Officer, Policy and Planning Staff, Justice
Management Division, United States Department of Justice, Two
Constitution Square, 145 N Street NE, 4W-218 Washington, DC 20530.
Dated: November 8, 2023.
Darwin Arceo,
Department Clearance Officer for PRA, U.S. Department of Justice.
[FR Doc. 2023-25327 Filed 11-15-23; 8:45 am]
BILLING CODE 4410-09-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.